Thursday October 17, 2019
SNc Channels:



Jul-09-2012 15:27printcomments

When will the U.S. Senate Investigate the Federal Drug Administration (FDA) Ties to Pharma?

An FDA spokesperson was quoted as saying "We're trying our best not to point fingers" when asked for the names of the pharmaceutical companies pushing these dangerous, unauthorized versions of OxyContin.

FDA logo and pills

(MYRTLE BEACH, SC) - This article is dedicated to "Michael David" -- every parent's child -- a beautiful young man, loved by many whose life was cut short before his dreams were realized. Fly with the angels, Michael you are very loved and wonderful memories will always be in the hearts of your mom and dad, family, friends and those who never even met you.

The FDA never disappoints me. The big news this week coming from the FDA is that they are "cracking down" on pharmaceutical companies manufacturing and distributing "unapproved" drugs that contain Oxycodone -- also known as OxyContin in time release formula. In a statement by the FDA, they cite these "unapproved" drugs containing the highly addictive ingredient in OxyContin had not been evaluated by the FDA for safety, effectiveness, manufacturing quality or appropriate labeling -- and cannot be legally marketed in the U.S. The FDA gave the "drug pushers" of these unapproved opioids 45 days to stop manufacturing the drugs.

An FDA spokesperson was quoted as saying "We're trying our best not to point fingers" when asked for the names of the pharmaceutical companies pushing these dangerous, unauthorized versions of OxyContin.

“It’s a high public health priority for FDA to remove these unapproved products from the market to minimize consumer exposure to drugs that may be unsafe, ineffective, and of poor quality,” said Ilisa Bernstein, acting director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research. “Since FDA-approved versions of these oral dosage forms are available by prescription, there should be no negative impact on consumers as a result of this action and no disruptions to the drug supply.”

In 2006, under the Unapproved Drugs Initiative, the FDA sought removal of these "unauthorized" drugs. Do you question what took the FDA so long to initiate this action? I sure do.

The FDA never disappoints me in their protection of big pharma. They don't seem to be concerned with the epidemic of prescription drugs in this country killing and addicting every day in the thousands. I'd like to point some fingers. Here's an email I received the other night from the FDA. I guess they wanted to impress me with their diligence at protecting the American people -- I wasn't impressed.

Hi Marianne,

I hope you had a wonderful Independence Day! FDA just issued a press release, in conjunction with a Federal Register notice, about action CDER is taking against unapproved oxycodone products as part of its Unapproved Drugs Initiative. You can find the press release and links to further information here: I thought you would be interested in this action and potentially sharing it within the activist community.


James E. Valentine, MHS
Program Analyst
Office of Special Health Issues
Office of the Commissioner
U.S. Food and Drug Administration
White Oak Bldg. 32 Rm. 5363
10903 New Hampshire Avenue
Silver Spring, MD 20993

I replied to this email -- "Too little, too late." I will continue to expose the FDA for their incompetence and lack of concern for the prescription drug deaths and addictions in this country.

And no I did not have an enjoyable Independence Day as mentioned in the FDA email to me. I had been on the phone with a dad who lost his 18 year old son the year before because his physician over-prescribed opioids to the boy -- even after the dad begged the physician to take his son off the dangerous narcotics. The boy had told his dad that he was becoming addicted. The reply the dad received from the doc was "your son needs them." He needed them so badly that he committed suicide and died in his dad's arms.

So call me cynical, but I am about finished with the FDA. For them to suggest that I share with the activist community their "too little, too late" action to protect the American consumer is an insult to the tens of thousands of families dealing with the loss of loved ones to death and addiction.

Last year I broke a story that the maker of OxyContin, Purdue Pharma was soliciting children ages 6 to 16 for clinical trials in the use of OxyContin. Links to my articles are provided below. My worst nightmare was realized this week when all major news media broke that Purdue Pharma had 150 children to ingest their highly addictive and lethal drug, OxyContin in clinical trials. It is being reported that by no means does it mean that the FDA will approve the use of OxyContin in children, it is to extend the patent of OxyContin for Purdue Pharm -- which will result in billions of dollars to them.

If you believe that OxyContin clinical trials for children is about patent extension, then I have a bridge to sell you.

How much more do families suffering horrific loss due to this prescription drug epidemic need to endure while the FDA plays "pick the pocket" of pharma?

Clinical trials of OxyContin on children ages 6 to 16 - links to my articles where I broke the story last year.

Marianne Skolek

Investigative Reporter for and
Columnist for American News
Activist for Victims of OxyContin and Purdue Pharma - a criminally convicted pharmaceutical company

_______________________________________ Investigative Reporter Marianne Skolek, is an Activist for Victims of OxyContin and Purdue Pharma throughout the United States and Canada. In July 2007, she testified against Purdue Pharma in Federal Court in Virginia at the sentencing of their three CEO's - Michael Friedman, Howard Udell and Paul Goldenheim - who pleaded guilty to charges of marketing OxyContin as less likely to be addictive or abused to physicians and patients. She also testified against Purdue Pharma at a Judiciary Hearing of the U.S. Senate in July 2007. Marianne works with government agencies and private attorneys in having a voice for her daughter Jill, who died in 2002 after being prescribed OxyContin, as well as the voice for scores of victims of OxyContin. She has been involved in her work for the past 8-1/2 years and is currently working on a book that exposes Purdue Pharma for their continued criminal marketing of OxyContin.

Marianne is a nurse having graduated in 1991 as president of her graduating class. She also has a Paralegal certification. Marianne served on a Community Service Board for the Courier News, a Gannet newspaper in NJ writing articles predominantly regarding AIDS patients and their emotional issues. She was awarded a Community Service Award in 1993 by the Hunterdon County, NJ HIV/AIDS Task Force in recognition of and appreciation for the donated time, energy and love in facilitating a Support Group for persons with HIV/AIDS.



Comments Leave a comment on this story.

All comments and messages are approved by people and self promotional links or unacceptable comments are denied.

Frost July 10, 2012 5:49 pm (Pacific time)

Watch wat hillbilly heroin can do? Then try to catch the doctors that deal it.

Amanda Leduc July 9, 2012 6:14 pm (Pacific time)

Thank you for your dedication to ensuring that the dangers of these drugs are known, and that the manufacturers be held accountable. I know several people whose lives have been deeply, negatively affected by pharmaceuticals. They are widely over prescribed and abused. I hope we can get this epidemic under control!

[Return to Top]
©2019 All opinions expressed in this article are those of the author and do not necessarily reflect those of

Articles for July 8, 2012 | Articles for July 9, 2012 | Articles for July 10, 2012
Tribute to Palestine and to the incredible courage, determination and struggle of the Palestinian People. ~Dom Martin

Annual Hemp Festival & Event Calendar

Special Section: Truth telling news about marijuana related issues and events.

Donate to and help us keep the news flowing! Thank you.

The NAACP of the Willamette Valley